Medicine
fromwww.theguardian.com
19 hours agoNovo Nordisk shares shoot up amid promising results for anti-obesity pill
Novo Nordisk’s once-daily oral GLP-1 pill produced weight loss nearly matching its Wegovy injection and boosted market value amid competition with Eli Lilly.